Institute of Health and Society, Newcastle University (United Kingdom)
Health of Population in Transition (Cameroon)
Ministry of Heath (Guinea)
Dr Eugene Sobngwi
Location of the project:
Guinea and Cameroon
November 1, 2008 - April 30, 2012
Glycated haemoglobin (HbA1c) is the best surrogate of average blood glucose control in people with diabetes. Large-scale studies in the USA and UK have demonstrated that lowering HbA1c significantly reduces diabetes complications. Moreover, immediate feedback of HbA1c measurement to patients improves control. However, HbA1c measurement is unavailable in most parts of Africa, a continent with one of the highest burden of diabetes. To translate these evidences, we will provide affordable access to HbA1c measurement and relevant education in 2 African countries, aiming at a significant improvement in diabetes control. We will develop a training and cost-recovery scheme with local health authorities for long-term sustainability.
Results to date (November 2012):
Overall, there was a 1% reduction in HbA1c in 12 months – 40% of the total sample reduced their HbA1c by more than 1 point. HbA1c determination has become routine in all 10 centres.
- Congrès de la Société Francophone Africaine de Diabétologie, Dakar (Senegal), December 2010 (2 posters)
- 6emes Journée Internationales d'Endocrinologie de Cotonou (Benin), January 2011
- Congrès annuel de la Société Francophone du Diabète, Geneva (Switzerland), March 2011 (2 posters)
- Diabetes Voice, June 2011 "Translating evidence into practice: Improving access to HBA1c in Sub-Saharan Africa" 
BRIDGES ended April 2012
BRIDGES (Bringing Research in Diabetes to Global Environments and Systems) is a programme initiated by the International Diabetes Federation , and supported by an educational grant from Lilly Diabetes.